Neogen Corporation Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities
Neogen Corporation (NEOG) reported Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities of $16.29 million for the 12-month period ending 2022-05-31, per its 10-K filed 2022-07-27.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities · last filed 2022-07-27
- Neogen Corporation increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2021-08-31 was -$2.38M.
- Neogen Corporation increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2020-08-31 was -$3.11M, a 182.79% decline year-over-year.
- Neogen Corporation increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2019-08-31 was $3.76M.
- Neogen Corporation increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2022 was $16.29M, a 15265.09% increase from fiscal 2021.
- Neogen Corporation increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2021 was $106.00K, a 98.51% decline from fiscal 2020.
- Neogen Corporation increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2020 was $7.10M.
- Neogen Corporation increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2019 was -$1.21M.
| Period end | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 3 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 12 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 12 month as first filed |
|---|---|---|---|
| 2022-05-31 | $16.29M 10-K · filed 2022-07-27 | ||
| 2021-08-31 | -$2.38M 10-Q · filed 2021-09-30 | ||
| 2021-05-31 | $106.00K 10-K · filed 2022-07-27 | ||
| 2020-08-31 | -$3.11M 10-Q · filed 2021-09-30 | ||
| 2020-05-31 | $7.10M 10-K · filed 2022-07-27 | ||
| 2019-08-31 | $3.76M 10-Q · filed 2020-09-30 | ||
| 2019-05-31 | -$1.21M 10-K · filed 2021-07-30 | ||
| 2018-05-31 | -$2.28M 10-K · filed 2020-07-30 | ||
| 2017-05-31 | $3.38M 10-K · filed 2019-07-30 | ||
| 2016-05-31 | $744.00K 10-K · filed 2018-07-27 | $385.00K 10-K · filed 2016-07-29 | |
| 2015-05-31 | $353.00K 10-K · filed 2017-07-28 | ||
| 2014-05-31 | $885.00K 10-K · filed 2016-07-29 | ||
| 2013-05-31 | -$451.00K 10-K · filed 2015-07-30 | ||
| 2012-05-31 | -$1.78M 10-K · filed 2014-07-30 | -$1.91M 10-K · filed 2012-07-30 | |
| 2011-05-31 | -$1.14M 10-K · filed 2013-07-30 | -$1.18M 10-K · filed 2012-07-30 | |
| 2010-05-31 | $3.48M 10-K · filed 2012-07-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |